Login / Signup

Treatment using tadalafil for severe pre-eclampsia with fetal growth restriction.

Hiroaki TanakaMichiko KuboMasafumi NiiSintarou MakiTakashi UmekawaTomoaki Ikeda
Published in: The journal of obstetrics and gynaecology research (2017)
For severe pre-eclampsia (PE) with fetal growth restriction (FGR), the only effective treatment is early delivery of the placenta. Clinicians are often forced to end the pregnancy because of maternal indications. We report a case of severe PE with FGR in which the PE was temporarily improved and pregnancy successfully prolonged with tadalafil, a phosphodiesterase 5 inhibitor. A 35-year-old primigravid woman presented at 27 3/7 weeks of gestation with severe PE and FGR. After commencing tadalafil administration, biochemical and angiogenic markers improved. Thereafter, hypertension and proteinuria temporarily improved. Importantly, the pregnancy was prolonged by 14 days after the initiation of tadalafil administration. Tadalafil may be a novel treatment for severe PE with FGR to prolong pregnancy.
Keyphrases
  • early onset
  • pregnancy outcomes
  • preterm birth
  • benign prostatic hyperplasia
  • blood pressure
  • palliative care
  • pregnant women
  • physical activity
  • case report
  • gestational age
  • weight gain